Walchandnagar Industries Reports No Deviation in Preferential Issue Fund Utilization for Q3 FY26

1 min read     Updated on 29 Jan 2026, 08:38 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Walchandnagar Industries Limited reported no deviation in its Rs. 247.59 crores preferential issue fund utilization for Q3 FY26. The company raised funds through fully convertible equity warrants in November 2023, with proceeds allocated across loan repayment, capital expenditure, and working capital. Strategic reallocations were implemented with board approval, and the Audit Committee confirmed compliance with all regulatory requirements.

31244881

*this image is generated using AI for illustrative purposes only.

Walchandnagar Industries Limited has filed its quarterly statement confirming no deviation in the use of proceeds raised through its preferential issue for the quarter ended December 31, 2025. The statement, submitted to stock exchanges on January 29, 2026, demonstrates the company's adherence to its original fund utilization plan as outlined in the Letter of Offer.

Fund Raising Details

The company raised Rs. 247.59 crores through the issue of fully convertible equity warrants on a preferential basis on November 03, 2023. The fund structure comprised Rs. 216.00 crores received from investors and Rs. 31.59 crores adjusted towards conversion of outstanding loans. ICRA Limited serves as the monitoring agency for the fund utilization.

Fund Utilization Breakdown

The proceeds have been allocated across five strategic objectives with specific utilization patterns:

Object Original Allocation Revised Allocation Funds Utilized
Loan Repayment to Promoters Rs. 31.59 crores Not Applicable Rs. 31.59 crores
Term Loan/Working Capital Repayment Rs. 41.00 crores Rs. 45.00 crores Rs. 45.00 crores
Capital Expenditure Rs. 105.00 crores Rs. 84.00 crores Rs. 59.96 crores
Working Capital Rs. 50.00 crores Rs. 67.00 crores Rs. 64.19 crores
General Corporate Purposes Rs. 20.00 crores Not Applicable Rs. 20.00 crores

Strategic Reallocation

The company implemented board-approved reallocations to optimize fund deployment. Rs. 4.00 crores was reallocated from capital expenditure to loan repayment, while Rs. 17.00 crores was shifted from capital expenditure to working capital requirements. Additionally, Rs. 21.00 crores from the capital expenditure allocation was utilized for loan repayment and working capital needs.

Compliance and Oversight

The Audit Committee reviewed the fund utilization in its meeting held on January 29, 2026, confirming compliance with regulatory requirements under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's auditors provided no adverse comments on the fund deployment strategy.

Current Status

As of December 31, 2025, the company has successfully utilized the raised funds according to its strategic priorities without any deviation from the approved objectives. The reallocations were executed through proper board resolutions, ensuring transparency and regulatory compliance throughout the process.

Historical Stock Returns for Walchandnagar Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+0.75%-1.17%+13.50%-5.98%-4.60%+170.78%
Walchandnagar Industries
View Company Insights
View All News
like15
dislike

Walchandnagar Industries Re-appoints Chirag C. Doshi as MD & CEO for 3 Years

2 min read     Updated on 29 Jan 2026, 08:13 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Walchandnagar Industries Limited announced the re-appointment of Mr. Chirag C. Doshi as Managing Director & CEO for a 3-year term starting April 1, 2026, following a board meeting on January 29, 2026. The company also approved relocating its registered office from Mumbai to Pune, with both decisions made under SEBI regulatory compliance requirements.

31243407

*this image is generated using AI for illustrative purposes only.

Walchandnagar Industries Limited announced the re-appointment of Mr. Chirag C. Doshi as Managing Director & CEO for a period of 3 years effective April 1, 2026. The decision was made during the Board of Directors meeting held on January 29, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Leadership Continuity

The board approved the re-appointment of Mr. Chirag C. Doshi based on the recommendation of the Nomination and Remuneration Committee. This marks his continued leadership role with the company, where he has been working since 1997 in various capacities.

Position Details: Information
Name: Mr. Chirag C. Doshi
DIN: 00181291
Position: Managing Director & CEO
Term Duration: 3 years
Effective Date: April 1, 2026
Reason: Re-Appointment
Approval Required: Subject to shareholder approval

Executive Profile and Experience

Mr. Chirag C. Doshi brings extensive experience to his continued leadership role, having worked with the company since 1997 in various capacities. The company highlighted his excellent contribution in day-to-day operations during his tenure as MD and subsequently as MD & CEO. His current term has been particularly notable for his role in the transformation of the company and efforts to bring the company back to profitability and make it long-term debt-free.

Family Relationships in Leadership

The disclosure revealed family relationships within the leadership structure. Mr. Chakor L. Doshi, who serves as Chairman, is the father of Managing Director & CEO Mr. Chirag C. Doshi. He is not related to any other Director of the Company.

Registered Office Relocation

The board has also approved relocating the company's registered office from its current Mumbai location to Pune. The move involves shifting from Flat No. 3, Walchand Terraces, Tardeo Road, Mumbai - 400 034 to Siddharth Towers, Building No.1, 9th Floor, S.No. 12/3-B, G. A. Kulkarni Path, Kothrud, Pune - 411 038.

Parameter: Details
Current Location: Flat No. 3, Walchand Terraces, Tardeo Road, Mumbai - 400 034
New Location: Siddharth Towers, Building No.1, 9th Floor, S.No. 12/3-B, G. A. Kulkarni Path, Kothrud, Pune - 411 038
Additional Changes: Amendment in Memorandum of Association (MoA)
Regulatory Compliance: Section 12 of Companies Act, 2013 with Rules 25 and 27

Regulatory Compliance

Both decisions align with regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosures were made pursuant to Regulation 30, read with Schedule III of the regulations and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The re-appointment of the Managing Director & CEO requires shareholder approval as per corporate governance norms.

Historical Stock Returns for Walchandnagar Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+0.75%-1.17%+13.50%-5.98%-4.60%+170.78%
Walchandnagar Industries
View Company Insights
View All News
like17
dislike

More News on Walchandnagar Industries

1 Year Returns:-4.60%